Top Markets
Coin of the day
Caladrius Biosciences, Inc. Caladrius Biosciences, Inc.

Caladrius Biosciences, Inc.

CLBS
Rangering i aksjer #33294
Caladrius Biosciences, Inc. operates as a clinical-stage biopharmaceutical... Caladrius Biosciences, Inc. operates as a clinical-stage biopharmaceutical company primarily engaged in the development and commercialization of cellular therapies. These therapies aim to either reverse various diseases or stimulate the regeneration of compromised tissue. The company's pipeline includes several key investigational therapies: HONEDRA, which has received the prestigious SAKIGAKE designation, is undergoing Phase II clinical trials as a potential treatment for critical limb ischemia; XOWNA is currently in Phase IIb trials targeting coronary microvascular dysfunction; and CLBS201, a CD34+ cell therapy, is being evaluated for chronic kidney disease in patients prior to requiring dialysis. Previously known as NeoStem, Inc., the firm adopted its current name, Caladrius Biosciences, Inc., in June 2015. Established in 1980, the company maintains its corporate headquarters in Basking Ridge, New Jersey.
Aksjekurs
$0.4264
Sist synkronisert: 2022-09-14
Markedsverdi
$7.93M
Endring (1 dag)
-16.44%
Endring (1 år)
0.00%
Land
US
Handel Caladrius Biosciences, Inc. (CLBS)

Kategori

Historikk for aksjesplitt for Caladrius Biosciences, Inc. (CLBS)
Aksjen Caladrius Biosciences, Inc. (symbol: CLBS) har gjennomgått totalt 0 aksjesplitt.
Den nyeste splittelsen skjedde Aug 17, 2026.
Én CLBS-aksje kjøpt før Aug 17, 2026 tilsvarer i dag 0 CLBS-aksjer.
Liste over aksjesplitt
År Splitt Multiplikator Kumulativ multiplikator
Ikke nok data for de angitte datoene.
Aksjesplitt for lignende selskaper eller konkurrenter
Selskap Antall aksjesplitt Kumulativ multiplikator Land
1 x2
US
0 -
NL
0 -
CH
0 -
KR
0 -
BE